Schultz leaves US FDA's device unit
This article was originally published in Clinica
Executive Summary
The head of the troubled US Center for Devices and Radiological Health (CDRH), Daniel Schultz, has resigned following months of investigation into allegations that scientists within the unit had been put under pressure to approve products they held concerns about.